NCT05268679View on ClinicalTrials.gov

Covid-19 Vaccine Response in Heart Transplant Recipients

CompletedOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

March 7, 2022

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Heart TransplantationCOVID-19 Virus InfectionCOVID-19 Vaccine
Interventions
OTHER

Biospecimen Collection

A blood of a sample of 2 x 7 mL will be collected for the analysis of the anti-SARS-CoV-2 T-cell response during a scheduled check-up as part of their routine follow-up

OTHER

Questionnaire

Patients who have received SARS-CoV-2 vaccination will be asked to complete the Vaccine tolerance questionnaire

OTHER

Electronic Health Record Review

For heart transplant recipients who were offered vaccination against SARS-CoV-2 medical records will be reviewed retrospectively.

Trial Locations (1)

75018

AP-HP, Bichat-Claude Bernard Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER